AkzoNobel maintains 2026 adjusted EBITDA guidance at around €1.47 billion

• AkzoNobel maintained its 2026 adjusted EBITDA forecast at around €1.47 billion.
• Volumes are expected to decline 1%, with pricing fully offsetting raw material and logistics inflation.
• Net industrial program benefits are forecast at €90 million, with leverage targeted at around 2 times.
• Third-quarter adjusted EBITDA reached €388 million; its margin rose 20 basis points to 15.3%.
• The proposed Axalta merger is expected to close in early 2027, targeting $600 million in annual pretax cost synergies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akzo Nobel NV published the original content used to generate this news brief on October 21, 2026, and is solely responsible for the information contained therein.